Molecules/LANADELUMAB

LANADELUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: Plasma kallikrein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

DX-2930LANADELUMABLANADELUMAB FLYOLANADELUMAB-FLYOLANADELUMAB (SHP643)SHP-643TAK-743Takhzyro

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LANADELUMAB

Loading drug network...